RF16 | PSUN335 Clinical Effects of Sodium Glucose Transporter Type 2 Inhibitors in Patients with Severe Insulin Resistance

por Bansal, Rashika, Brown, Rebecca, Cochran, Elaine, Startzell, Megan
Publicado 2022

OR18-04 Leptin Decreases Gluconeogenesis And Gluconeogenic Substrate Availability In Patients With Lipodystrophy

por Quaye, Emmanuel, Chacko, Shaji, Startzell, Megan, Brown, Rebecca J
Publicado 2023

Racial Disparities Among Clinical Trials for Inherited Forms of Lipodystrophy

por Abel, Brent S, Cochran, Elaine K, Startzell, Megan S, Brown, Rebecca J
Publicado 2021

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII

por Brite, Brianna, Lightbourne, Marissa, Startzell, Megan S, Shamburek, Robert, Brown, Rebecca J
Publicado 2021

THU301 Natural History Of Pregnancy And Pregnancy Outcomes In Subjects With Lipodystrophy

por Neal, Trinity J, Startzell, Megan S, Cochran, Elaine, Lightbourne, Marissa, Brown, Rebecca J
Publicado 2023

OR08-04 Differences in Advanced Lipoprotein Profile Between Rabson-Mendenhall Syndrome and Lipodystrophy

por Al-Jundi, Mohammad, Lightbourne, Marissa, Startzell, Megan, Shamburek, Robert D, Brown, Rebecca J
Publicado 2020

Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans

por Haykal, Rasha, Kinzer, Alexandra, Abel, Brent, Startzell, Megan S, Cochran, Elaine, Brown, Rebecca J
Publicado 2021

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy

por Lightbourne, Marissa, Brite, Brianna, Startzell, Megan S, Kimberley, Bruce, Eckel, Robert, Brown, Rebecca J
Publicado 2021

THU268 Hyperuricemia In Insulin Resistance Is Associated With Increased Synthesis And Not Decreased Renal Excretion Of Uric Acid In Humans

por Haykal, Rasha, Kinzer, Alexandra, Abel, Brent, Lightbourne, Marissa, Startzell, Megan S, Cochran, Elaine, Brown, Rebecca J
Publicado 2023

SUN-LB4 Androgenic Profiles of Patients With Severe Insulin Resistance

por Jha, Smita, Turcu, Adina, Brookner, Brittany, Abel, Brent Samuel, Startzell, Megan, Auchus, Richard Joseph, Brown, Rebecca J, Merke, Deborah P
Publicado 2020

SUN-565 The Effect of Leptin Treatment on Blood Pressure and Autonomic Nervous System Function in Patients with Lipodystrophy

por Grover, Andrew, Brychta, Robert J, Startzell, Megan, Chen, Kong, Marshall, Brandon, Christensen, John, Meehan, Cristina, Valencia, Areli, Gorden, Phillip, Brown, Rebecca J
Publicado 2020

Leptin Decreases Energy Expenditure but Increases Thyroid Hormone in Patients With Lipodystrophy

por Quaye, Emmanuel, Grover, Andrew, Brychta, Robert, Christensen, John, Startzell, Megan S, Meehan, Cristina A, Valencia, Areli, Marshall, Brandon, Chen, Kong, Brown, Rebecca J
Publicado 2021

MON-611 Biux2x2

por Kushchayeva, Yevgeniya, Kothari, Pankti, Kinzer, Alexandra, Startzell, Megan, Cochran, Elaine, Lightbourne, Marissa, Auh, Sungyoung, Lin, Tzu-Chun, Skarulis, Monica, Shamburek, Robert, Brown, Rebecca
Publicado 2019

OR17-01 Leptin Decreases De Novo Lipogenesis in Lipodystrophic Patients

por Baykal, Annah Petek, Parks, Elizabeth J, Shamburek, Robert, Chung, Stephanie, Syed-Abdul, Majid M, Muniyappa, Ranganath, Cochran, Elaine, Startzell, Megan, Gharib, Ahmed M, Ouwerkerk, Ronald, Walter, Peter J, Brown, Rebecca J
Publicado 2020

MON-LB055 A Single Center Experience of Multiple Endocrine Neoplasia Type 1 (MEN1) vs Sporadic Insulinoma: What Can We Learn and Where Are We Going?

por Itatani, Miho, El-Maouche, Diala, Welch, James, Startzell, Megan, Cochran, Craig, Merkel, Roxanne, Tepede, Aisha, Mandl, Adel, Agarwal, Sunita, Tirosh, Amit, Sadowski Veuthey, Samira, Nilubol, Naris, Simonds, William, Weinstein, Lee, Chang, Richard, Gorden, Phillip, Blau, Jenny
Publicado 2019